NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/30/2026
Back to search
Official data from USPTO
APRIORI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
APRIORI
ST13
US500000097287505Class
1, 5, 42
Filing
97287505
Registration
8325673
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
06/30/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
02/28/2022
Registration date
06/30/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/30/2026
Last transaction
06/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/29/2026
First use in commerce
05/29/2026
Drawing code
4
Owner type
03
Owner location
CAMBRIDGE, MA, US
Examiner
WHEATLEY, TRAVIS DWIGHT
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
APRIORI BIO, INC.
Flagship Labs 77, Inc.
Representatives
Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for scientific or medical research use; reagents for research purposes in the field of drug discovery and development
Class 5
Therapeutic products for the treatment of diseasetherapeutic pharmaceuticals for the treatment of viral diseases and infectious diseases; pharmaceutical preparations and products for the treatment of viral diseases and infectious diseases; vaccines; chemical reagents for medical purposes; diagnostic products for the diagnosis of disease or health statusdiagnostic preparations for medical use
Class 42
Technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biologybioinformaticsgenomicsbiotechnologyimmunology and pharmaceuticals; Software as a service (SAAS) services featuring software for data analysis in the fields of biomedical and genomic research; software as a service (SAAS) services featuring software for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; software as a service (SAAS) services featuring software for predictive analytics in the fields of biomedical and genomic research
Publications
History of USPTO decisions and trademark events.
54 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/30/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/10/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/10/2026
DOCK
ASSIGNED TO EXAMINER
06/09/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/03/2026
IUAF
USE AMENDMENT FILED
05/29/2026
EISU
TEAS STATEMENT OF USE RECEIVED
05/29/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/01/2026
EX5G
SOU EXTENSION 5 GRANTED
04/30/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/30/2026
EEXT
SOU TEAS EXTENSION RECEIVED
11/25/2025
EXT5
SOU EXTENSION 5 FILED
11/24/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/15/2025
EX4G
SOU EXTENSION 4 GRANTED
05/29/2025
EXT4
SOU EXTENSION 4 FILED
05/28/2025
EEXT
SOU TEAS EXTENSION RECEIVED
05/28/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EX3G
SOU EXTENSION 3 GRANTED
11/26/2024
EXT3
SOU EXTENSION 3 FILED
11/26/2024
EEXT
SOU TEAS EXTENSION RECEIVED
11/26/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/30/2024
EX2G
SOU EXTENSION 2 GRANTED
05/29/2024
EXT2
SOU EXTENSION 2 FILED
05/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
05/29/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/24/2023
EX1G
SOU EXTENSION 1 GRANTED
11/22/2023
EXT1
SOU EXTENSION 1 FILED
11/22/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/22/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/30/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2023
PUBO
PUBLISHED FOR OPPOSITION
04/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/28/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/27/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/27/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/27/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/27/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/24/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/14/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/27/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
01/27/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/27/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
01/27/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/27/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/19/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/19/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/19/2022
GNRT
NON-FINAL ACTION E-MAILED
12/19/2022
CNRT
NON-FINAL ACTION WRITTEN
12/19/2022
DOCK
ASSIGNED TO EXAMINER
12/12/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/13/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/03/2022
Continuous trademark protection
Get notified about every new filing that threatens APRIORI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.